Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Bankwell Financial Group (NASDAQ: BWFG) Director Buys 261 Shares at $67.11

Bankwell Financial Group, Inc. (NASDAQ: BWFG) director Jeffrey R. Dunne bought 261 shares at $67.11 per share on Sep. 8, 2026. Following the transaction, the filing reported his ownership at 6,381 shares.

Vinay Lochav | 10 September 2026

AvePoint (NASDAQ: AVPT) Legal Officer Forfeits 4,092 Shares at $13.43

AvePoint, Inc. (NASDAQ: AVPT) Chief Legal Officer Brown Brian Michael forfeited 4,092 shares at $13.43 per share. His reported ownership after the transactions was 346,528 shares.

Vinay Lochav | 10 September 2026

Avidbank Holdings (NASDAQ: AVBH) Director Sells 1,500 Shares at $31.45

Avidbank Holdings, Inc. (NASDAQ: AVBH) shares were sold by director Mike Rosinus at $31.45 each on 9 September 2026. The transaction involved 1,500 shares, with the director retaining 16,680 shares afterward.

Vinay Lochav | 10 September 2026

Ball Corporation (NYSE: BALL) Directors Nicosia and Buck Begin September 21

Ball Corporation (NYSE: BALL) will add Darlene Nicosia and Sherry Buck to its board of directors beginning September 21. The appointments place executives with backgrounds in food and beverage operations, manufacturing and corporate finance on the board, with committee assignments spanning finance, audit and …

Vinay Lochav | 10 September 2026

Anteris Technologies Names CFO With $475,000 Salary (NASDAQ: AVR)

Anteris Technologies Global Corp. (NASDAQ: AVR) appointed Brent Moen as chief financial officer effective September 11, 2026, under an employment agreement carrying an annual base salary of $475,000. The transition places Moen in the finance role while Matthew McDonnell moves to Head of Australia …

Vinay Lochav | 10 September 2026

Ascendis Pharma (NASDAQ: ASND) Employee Warrants Set $270.09 Exercise Price

Ascendis Pharma A/S (NASDAQ: ASND) granted 29,380 warrants to certain employees on September 8, 2026.

Vinay Lochav | 10 September 2026

Ascendis Pharma A/S Executive Exercises 3,000 Options at $110 (NASDAQ: ASND)

Ascendis Pharma A/S (NASDAQ: ASND) executive Bodenhoff Mads exercised options covering 3,000 shares at $110 per share on September 8, 2026. The transactions left Mads with 0 shares and 687 derivative securities after the activity.

Vinay Lochav | 10 September 2026

Aspen Insurance Holdings Reports $53.8M Six-Month Net Loss

Aspen Insurance Holdings Limited recorded a net loss after income tax of $53.8 million for the six months ended June 30, 2026, compared with income of $83.3 million in the corresponding 2025 period. Net loss available to ordinary shareholders was $75.7 million, versus income …

Vinay Lochav | 10 September 2026

Aspire Biopharma Holdings, Inc. Approves $10M Share Repurchase Program

Aspire Biopharma Holdings, Inc. authorized a $10 million common stock repurchase program effective September 9, giving the board authority to buy shares through open-market or privately negotiated transactions. The company also changed its name to Aspire-Lakewood Holdings, Inc. while retaining its Nasdaq listing and …

Vinay Lochav | 10 September 2026

Ategrity Specialty Insurance Awards 125,658 Derivative Securities (NYSE: ASIC)

Ategrity Specialty Insurance Co Holdings (NYSE: ASIC) awarded Schenk Chris 125,658 derivative securities at $0 per share. The award was recorded on September 4, 2026, across two transactions.

Vinay Lochav | 10 September 2026
Support

Hi! How can we help you today?

Loading…